Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Cash Flow Reinvestment Rate
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Reinvestment Rate of 7.80x as of December 2024, reinvesting CN¥187.51 Million (capex CN¥187.14 Million plus investments CN¥369.80K) from operating cash flow of CN¥24.04 Million. See Hunan Dajiaweikang Pharmaceutical Indust free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. For the full cash flow conversion analysis, see 301126 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year capital reinvestment analysis for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. See 301126 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.80x | CN¥187.51 Million | CN¥24.04 Million | CN¥187.14 Million | ▼ -9.7% |
| 2023 | 8.64x | CN¥234.43 Million | CN¥27.13 Million | CN¥226.70 Million | ▲ +1706.6% |
| 2019 | 0.48x | CN¥65.01 Million | CN¥135.91 Million | CN¥32.50 Million | — |